advertisement

Topcon

Hu M 22

Showing records 1 to 22 | Display all abstracts from Hu M

117826 Xiaoqing: A Q&A model for glaucoma based on LLMs
Xue X
Computers in Biology and Medicine 2024; 174: 108399
117443 Geniposide Attenuates Oxygen-glucose Deprivation/Recovery-induced Retinal Ganglion Cell Injury via Akt/Nrf-2 Signaling Pathway
Hu M
Current Medicinal Chemistry 2024; 0:
118901 Detection and analysis of signals of adverse events of memantine based on the US food and drug administration adverse event reporting system
Zhang W
Expert Opinion on Drug Safety 2024; 23: 617-625
117826 Xiaoqing: A Q&A model for glaucoma based on LLMs
Zhang D
Computers in Biology and Medicine 2024; 174: 108399
117443 Geniposide Attenuates Oxygen-glucose Deprivation/Recovery-induced Retinal Ganglion Cell Injury via Akt/Nrf-2 Signaling Pathway
Chen D
Current Medicinal Chemistry 2024; 0:
118901 Detection and analysis of signals of adverse events of memantine based on the US food and drug administration adverse event reporting system
Chen M
Expert Opinion on Drug Safety 2024; 23: 617-625
117443 Geniposide Attenuates Oxygen-glucose Deprivation/Recovery-induced Retinal Ganglion Cell Injury via Akt/Nrf-2 Signaling Pathway
Wu X
Current Medicinal Chemistry 2024; 0:
118901 Detection and analysis of signals of adverse events of memantine based on the US food and drug administration adverse event reporting system
Cai X
Expert Opinion on Drug Safety 2024; 23: 617-625
117826 Xiaoqing: A Q&A model for glaucoma based on LLMs
Sun C
Computers in Biology and Medicine 2024; 174: 108399
118901 Detection and analysis of signals of adverse events of memantine based on the US food and drug administration adverse event reporting system
Zhang M
Expert Opinion on Drug Safety 2024; 23: 617-625
117443 Geniposide Attenuates Oxygen-glucose Deprivation/Recovery-induced Retinal Ganglion Cell Injury via Akt/Nrf-2 Signaling Pathway
Ren GF
Current Medicinal Chemistry 2024; 0:
117826 Xiaoqing: A Q&A model for glaucoma based on LLMs
Shi Y
Computers in Biology and Medicine 2024; 174: 108399
118901 Detection and analysis of signals of adverse events of memantine based on the US food and drug administration adverse event reporting system
Hu M
Expert Opinion on Drug Safety 2024; 23: 617-625
117826 Xiaoqing: A Q&A model for glaucoma based on LLMs
Wang R
Computers in Biology and Medicine 2024; 174: 108399
118901 Detection and analysis of signals of adverse events of memantine based on the US food and drug administration adverse event reporting system
Hu Y
Expert Opinion on Drug Safety 2024; 23: 617-625
117826 Xiaoqing: A Q&A model for glaucoma based on LLMs
Tan T; Gao P
Computers in Biology and Medicine 2024; 174: 108399
118901 Detection and analysis of signals of adverse events of memantine based on the US food and drug administration adverse event reporting system
Yang Y; Zhu J
Expert Opinion on Drug Safety 2024; 23: 617-625
117826 Xiaoqing: A Q&A model for glaucoma based on LLMs
Fan S
Computers in Biology and Medicine 2024; 174: 108399
118901 Detection and analysis of signals of adverse events of memantine based on the US food and drug administration adverse event reporting system
Du Y
Expert Opinion on Drug Safety 2024; 23: 617-625
117826 Xiaoqing: A Q&A model for glaucoma based on LLMs
Zhai G; Hu M
Computers in Biology and Medicine 2024; 174: 108399
118901 Detection and analysis of signals of adverse events of memantine based on the US food and drug administration adverse event reporting system
Yang C
Expert Opinion on Drug Safety 2024; 23: 617-625
117826 Xiaoqing: A Q&A model for glaucoma based on LLMs
Wu Y
Computers in Biology and Medicine 2024; 174: 108399

Issue 24-4

Change Issue


advertisement

Nidek